ArticleOncogene2022

Distinct roles of treatment schemes and BRCA2 on the restoration of homologous recombination DNA repair and PARP inhibitor resistance in ovarian cancer.

Tzu-Ting Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.